| Particulars |
| Company Name |
Bafna Pharmaceuticals Ltd |
| Face Value |
10 |
| BSE Code |
532989 |
| Year End |
202403 |
| Full Year |
| Equity (Rs . Cr) |
23.66 |
| B.V. (Rs) |
35.00 |
| Sales (Rs . Cr) |
152.47 |
| NP (Rs . Cr) |
7.28 |
| NP Var% |
-35.00 |
| Div% |
0.00 |
| CPS (Rs) |
5.20 |
| EPS (Rs) |
3.10 |
| Traded Value(Rs . Lakhs) |
0.92 |
| 52 Week High |
112.00 |
| 52 Week Low |
68.00 |
| Price BSE |
80.00 |
| Price NSE |
80.00 |
| Market Capital(Rs . Cr) |
188.64 |
| P/C Ratio |
15.40 |
| P/E Ratio |
26.00 |
| Price Vs.BV |
2.29 |
| Latest Quarter |
| Year End |
202412 |
| Sales (Rs . Cr) |
33.19 |
| NP (Rs . Cr) |
0.96 |
| NP Var % |
133.00 |
| Trailing Twelve Months |
| Year End |
202412 |
| Sales |
143.45 |
| OPM |
4.06 |
| NP |
0.75 |
| NP Var% |
-58.68 |
| EPS |
1.97 |
| PE |
40.48 |
|